Drug-Coated Balloons Market - Global Outlook and Forecast 2020-2025
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Drug-Coated Balloons Market Report
The drug-coated balloons market by revenue is expected to grow at a CAGR of 15% during the period 2019–2025.
The global drug-coated balloons market is one of the fastest-growing segments in the cardiovascular devices market. The market is growing significantly due to the surge in incidence/prevalence of cardiovascular diseases, especially peripheral artery and coronary artery diseases across the globe.
The COVID-19 pandemic is likely to profoundly affect the drug-coated balloons market in several countries across the globe. With the spread of the pandemic, several hospitals, CATH labs, and ASCs have experienced a rapid decline in the volume of elective cardiology procedures. Although COVID-19 is a global pandemic, some countries have experienced a higher incidence of the virus than others.
The following factors are likely to contribute to the growth of the the drug-coated balloons market during the forecast period:
Global Drug-Coated Balloons Market Segmentation
The global drug-coated balloons market research report includes a detailed segmentation by indication, drug type, end-user, geography. The peripheral artery disease (PAD) segment accounted for a share of over 81% in 2019, and it is expected to retain its market dominance during the forecast period. The adoption of drug-coated balloons (DCB) for treating PAD is growing rapidly, primarily due to the availability of positive clinical data, supporting the safety and efficacy of DCB technology. The segment accounts for the largest share as the majority of DCB devices are commercially available for PAD indication. However, despite high potential growth opportunities for treating PAD, the recent COVID-19 pandemic has caused unprecedented challenges to perform PCI procedures. The spread of the virus has triggered disruption across the globe with lockdowns, travel bans, and ban on large gatherings such as major cardiac scientific society meetings being canceled, with substantial pressure on the health care services across the world.
The paclitaxel segment accounts for the maximum market share as these devices are safe and effective in treating CVDs, AV, and urological disorders. Paclitaxel-coated balloon (PCB) technology has emerged as a promising therapeutic alternative in the PCI procedure, especially for CVDs. The majority of commercially available DCBs are paclitaxel-coated. Paclitaxel-coated balloons are clinically proven, reducing the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. This is increasing their demand among healthcare professionals. In 2019, the sirolimus segment accounted for over 3% of the market. This segment is a new generation of DCBs, where balloons are coated with a medicine called sirolimus. There are a few commercially available sirolimus DCBs. Thus the contribution of the segment is low than paclitaxel-coated balloons.
The global drug-coated balloons market is segmented into hospitals, freestanding CATH labs, and ASCs. Healthcare professionals in hospitals use DCBs mainly for cardiovascular disorders, including AV interventions, urological, and neurovascular procedures. The segment is growing at a healthy rate due to the high adoption of the latest generation DCBs. A majority of patients with an increased risk of cardiovascular diseases prefer visiting hospitals for treatment due to advanced infrastructure facilities available in major private and public hospitals, the segment is expected to grow significantly.
By Indication
North America occupies a dominant position in the global drug-coated balloons market. The presence of a large disease population, coupled with better access to treatment, is the primary factor for the high market share. The market in North America is expected to witness lucrative growth during the forecast period due to expanded indication approvals for commercialized DCBs, new product approvals, and the availability of abundant clinical evidence.
By Geography
The global drug-coated balloons market is highly dynamic with the presence of global, regional, and local players offering a broad range of latest-generation DCBs for end-users. Medtronic, BD, Koninklijke Philips, Boston Scientific, and B. Braun Melsungen are the key vendors in the market in terms of technology, safety features, regulatory approvals, marketing strategies, and distribution channels.
Prominent Vendors
1. What is the drug-coated balloons market size and growth rate during the forecast period?
2. What are the factors impacting the growth of the drug-coated balloons market share?
3. What is the growth of North America drug-coated balloons market during the forecast period?
4. Who are the leading vendors in the drug-coated balloons market?
5. What is the impact of COVID-19 pandemic on the global market?
The drug-coated balloons market by revenue is expected to grow at a CAGR of 15% during the period 2019–2025.
The global drug-coated balloons market is one of the fastest-growing segments in the cardiovascular devices market. The market is growing significantly due to the surge in incidence/prevalence of cardiovascular diseases, especially peripheral artery and coronary artery diseases across the globe.
The COVID-19 pandemic is likely to profoundly affect the drug-coated balloons market in several countries across the globe. With the spread of the pandemic, several hospitals, CATH labs, and ASCs have experienced a rapid decline in the volume of elective cardiology procedures. Although COVID-19 is a global pandemic, some countries have experienced a higher incidence of the virus than others.
The following factors are likely to contribute to the growth of the the drug-coated balloons market during the forecast period:
- Expanding Indications of Drug-Coated Balloons
- Emergence of Latest Generation DCBs
- Growth in Target Patient Pool across the Globe
Global Drug-Coated Balloons Market Segmentation
The global drug-coated balloons market research report includes a detailed segmentation by indication, drug type, end-user, geography. The peripheral artery disease (PAD) segment accounted for a share of over 81% in 2019, and it is expected to retain its market dominance during the forecast period. The adoption of drug-coated balloons (DCB) for treating PAD is growing rapidly, primarily due to the availability of positive clinical data, supporting the safety and efficacy of DCB technology. The segment accounts for the largest share as the majority of DCB devices are commercially available for PAD indication. However, despite high potential growth opportunities for treating PAD, the recent COVID-19 pandemic has caused unprecedented challenges to perform PCI procedures. The spread of the virus has triggered disruption across the globe with lockdowns, travel bans, and ban on large gatherings such as major cardiac scientific society meetings being canceled, with substantial pressure on the health care services across the world.
The paclitaxel segment accounts for the maximum market share as these devices are safe and effective in treating CVDs, AV, and urological disorders. Paclitaxel-coated balloon (PCB) technology has emerged as a promising therapeutic alternative in the PCI procedure, especially for CVDs. The majority of commercially available DCBs are paclitaxel-coated. Paclitaxel-coated balloons are clinically proven, reducing the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. This is increasing their demand among healthcare professionals. In 2019, the sirolimus segment accounted for over 3% of the market. This segment is a new generation of DCBs, where balloons are coated with a medicine called sirolimus. There are a few commercially available sirolimus DCBs. Thus the contribution of the segment is low than paclitaxel-coated balloons.
The global drug-coated balloons market is segmented into hospitals, freestanding CATH labs, and ASCs. Healthcare professionals in hospitals use DCBs mainly for cardiovascular disorders, including AV interventions, urological, and neurovascular procedures. The segment is growing at a healthy rate due to the high adoption of the latest generation DCBs. A majority of patients with an increased risk of cardiovascular diseases prefer visiting hospitals for treatment due to advanced infrastructure facilities available in major private and public hospitals, the segment is expected to grow significantly.
By Indication
- PAD
- CAD
- Others
- Paclitaxel
- Sirolimus
- Hospitals
- Ambulatory Care Settings
- Freestanding Cath Labs
North America occupies a dominant position in the global drug-coated balloons market. The presence of a large disease population, coupled with better access to treatment, is the primary factor for the high market share. The market in North America is expected to witness lucrative growth during the forecast period due to expanded indication approvals for commercialized DCBs, new product approvals, and the availability of abundant clinical evidence.
By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- Japan
- South Korea
- India
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- Turkey
- South Africa
- Israel
The global drug-coated balloons market is highly dynamic with the presence of global, regional, and local players offering a broad range of latest-generation DCBs for end-users. Medtronic, BD, Koninklijke Philips, Boston Scientific, and B. Braun Melsungen are the key vendors in the market in terms of technology, safety features, regulatory approvals, marketing strategies, and distribution channels.
Prominent Vendors
- Medtronic
- BD
- Koninklijke Philips
- Boston Scientific
- B. Braun Melsungen
- Aachen Resonance
- Acotec Scientific
- AR Baltic Medical
- Biosensors International Group
- BIOTRONIK
- Cardionovum
- Concept Medical
- eucatech
- ENDOCOR
- HEXACATH
- iVascular
- M.A. Med Alliance
- Meril Life Sciences
- Nano Therapeutics
- QT Vascular
- RD Global-Invamed
- STENTYS
- Surmodics
- Terumo
- Urotronic
- Wellinq
1. What is the drug-coated balloons market size and growth rate during the forecast period?
2. What are the factors impacting the growth of the drug-coated balloons market share?
3. What is the growth of North America drug-coated balloons market during the forecast period?
4. Who are the leading vendors in the drug-coated balloons market?
5. What is the impact of COVID-19 pandemic on the global market?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation By Indication
4.4.2 Market Segmentation By Drug Type
4.4.3 Market Segmentation By End-User
4.4.4 Market Segmentation By Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Drug Coated Balloons (DCBS): An Overview
7.1.1 Background
7.1.2 Use Of DCBS
8 MARKET OPPORTUNITIES & TRENDS
8.1 Increased Application Of DCBS To Treat Medical Disorders
8.2 Promising Investigational Drug-Coated Balloons
8.3 Emergence Of New Generation DCBS
9 MARKET GROWTH ENABLERS
9.1 Global Increase In Target Patient Pool
9.2 Increasing Demand For DCBS Due To Promosing Outcomes
9.3 Increased Focus On Generating Abundant Clinical Data
9.4 New Product Approvals/Launches
10 MARKET RESTRAINTS
10.1 Presence Ofalternative Treatment Procedures
10.2 Stringency In Regulatory Approvals
10.3 Lack Of Reimbursement Coverage For DCBS
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Covid-19 Impact On Global Drug-Coated Balloons Market
11.3 Market Size & Forecast
11.3.1 Geographic Insights
11.3.2 Indication Insights
11.3.3 Drug Type
11.3.4 End-User Insights
11.4 Five Forces Analysis
11.4.1 Threat Of New Entrants
11.4.2 Bargaining Power Of Suppliers
11.4.3 Bargaining Power Of Buyers
11.4.4 Threat Of Substitutes
11.4.5 Competitive Rivalry
12 INDICATION
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 PAD
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 CAD
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Others
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 DRUG TYPE
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Paclitaxel
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Sirolimus
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 END-USER
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Freestanding Cath Labs
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 ASCS
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 GEOGRAPHY
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 NORTH AMERICA
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 US: Market Size & Forecast
16.3.2 Canada: Market Size & Forecast
17 EUROPE
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Germany: Market Size & Forecast
17.3.2 France: Market Size & Forecast
17.3.3 UK: Market Size & Forecast
17.3.4 Italy: Market Size & Forecast
17.3.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.4 Key Countries
18.4.1 Japan: Market Size & Forecast
18.4.2 China: Market Size & Forecast
18.4.3 Australia: Market Size & Forecast
18.4.4 South Korea: Market Size & Forecast
18.4.5 India: Market Size & Forecast
19 LATIN AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Brazil: Market Size & Forecast
19.3.2 Mexico: Market Size & Forecast
19.3.3 Argentina: Market Size & Forecast
20 MIDDLE EAST & AFRICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 Saudi Arabia: Market Size & Forecast
20.3.3 Israel: Market Size & Forecast
20.3.4 South Africa: Market Size & Forecast
21 COMPETITIVE LANDSCAPE
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Medtronic
21.2.2 BD
21.2.3 Koninklijke Philips
21.2.4 Boston Scientific
21.2.5 B. Braun Melsungen
22 KEY COMPANY PROFILES
22.1 Medtronic
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 BD
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Koninklijke Philips
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Boston Scientific
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 B. Braun Melsungen
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
23 OTHER PROMINENT VENDORS
23.1 Aachen Resonance
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Acotec Scientific
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Ar Baltic Medical
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Biosensors International Group
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Biotronik
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Cardionovum
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Concept Medical
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Eucatech
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Endocor
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 Hexacath
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Ivascular
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 M.A. Med Alliance
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Meril Life Sciences
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Nano Therapeutics
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 QT Vascular
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Rd Global-Invamed
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 Stentys
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Surmodics
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Terumo
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Urotronic
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Wellinq
23.21.1 Business Overview
23.21.2 Product Offerings
24 INVESTIGATIONAL COMPANIES
24.1 Micell Technologies
24.1.1 Business Overview
24.1.2 Investigational Products
24.2 Orchestra Biomed
24.2.1 Business Overview
24.2.2 Investigational Products
25 REPORT SUMMARY
25.1 Key Takeaways
25.2 Strategic Recommendations
26 QUANTITATIVE SUMMARY
26.1 Indication
26.2 Drug Type
26.3 End-User
26.4 Geography
27 APPENDIX
27.1 Abbreviations
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation By Indication
4.4.2 Market Segmentation By Drug Type
4.4.3 Market Segmentation By End-User
4.4.4 Market Segmentation By Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Drug Coated Balloons (DCBS): An Overview
7.1.1 Background
7.1.2 Use Of DCBS
8 MARKET OPPORTUNITIES & TRENDS
8.1 Increased Application Of DCBS To Treat Medical Disorders
8.2 Promising Investigational Drug-Coated Balloons
8.3 Emergence Of New Generation DCBS
9 MARKET GROWTH ENABLERS
9.1 Global Increase In Target Patient Pool
9.2 Increasing Demand For DCBS Due To Promosing Outcomes
9.3 Increased Focus On Generating Abundant Clinical Data
9.4 New Product Approvals/Launches
10 MARKET RESTRAINTS
10.1 Presence Ofalternative Treatment Procedures
10.2 Stringency In Regulatory Approvals
10.3 Lack Of Reimbursement Coverage For DCBS
11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Covid-19 Impact On Global Drug-Coated Balloons Market
11.3 Market Size & Forecast
11.3.1 Geographic Insights
11.3.2 Indication Insights
11.3.3 Drug Type
11.3.4 End-User Insights
11.4 Five Forces Analysis
11.4.1 Threat Of New Entrants
11.4.2 Bargaining Power Of Suppliers
11.4.3 Bargaining Power Of Buyers
11.4.4 Threat Of Substitutes
11.4.5 Competitive Rivalry
12 INDICATION
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 PAD
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 CAD
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Others
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 DRUG TYPE
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Paclitaxel
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Sirolimus
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 END-USER
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Freestanding Cath Labs
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 ASCS
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 GEOGRAPHY
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 NORTH AMERICA
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 US: Market Size & Forecast
16.3.2 Canada: Market Size & Forecast
17 EUROPE
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Germany: Market Size & Forecast
17.3.2 France: Market Size & Forecast
17.3.3 UK: Market Size & Forecast
17.3.4 Italy: Market Size & Forecast
17.3.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.4 Key Countries
18.4.1 Japan: Market Size & Forecast
18.4.2 China: Market Size & Forecast
18.4.3 Australia: Market Size & Forecast
18.4.4 South Korea: Market Size & Forecast
18.4.5 India: Market Size & Forecast
19 LATIN AMERICA
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Brazil: Market Size & Forecast
19.3.2 Mexico: Market Size & Forecast
19.3.3 Argentina: Market Size & Forecast
20 MIDDLE EAST & AFRICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 Saudi Arabia: Market Size & Forecast
20.3.3 Israel: Market Size & Forecast
20.3.4 South Africa: Market Size & Forecast
21 COMPETITIVE LANDSCAPE
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Medtronic
21.2.2 BD
21.2.3 Koninklijke Philips
21.2.4 Boston Scientific
21.2.5 B. Braun Melsungen
22 KEY COMPANY PROFILES
22.1 Medtronic
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 BD
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Koninklijke Philips
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Boston Scientific
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 B. Braun Melsungen
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
23 OTHER PROMINENT VENDORS
23.1 Aachen Resonance
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Acotec Scientific
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 Ar Baltic Medical
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Biosensors International Group
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Biotronik
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 Cardionovum
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Concept Medical
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Eucatech
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Endocor
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 Hexacath
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Ivascular
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 M.A. Med Alliance
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 Meril Life Sciences
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 Nano Therapeutics
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 QT Vascular
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Rd Global-Invamed
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 Stentys
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Surmodics
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Terumo
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Urotronic
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Wellinq
23.21.1 Business Overview
23.21.2 Product Offerings
24 INVESTIGATIONAL COMPANIES
24.1 Micell Technologies
24.1.1 Business Overview
24.1.2 Investigational Products
24.2 Orchestra Biomed
24.2.1 Business Overview
24.2.2 Investigational Products
25 REPORT SUMMARY
25.1 Key Takeaways
25.2 Strategic Recommendations
26 QUANTITATIVE SUMMARY
26.1 Indication
26.2 Drug Type
26.3 End-User
26.4 Geography
27 APPENDIX
27.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Drug-coated Balloons Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Key Application Areas of DCBs
Exhibit 4 Market Dynamics of DCBs
Exhibit 5 Global Drug-coated Balloons Market by Geography 2019 (%)
Exhibit 6 Global Drug-coated Balloons Market by Indication 2019 (%)
Exhibit 7 Impact of Increased Application of DCBs to Treat Medical Disorders
Exhibit 8 Impact of Promising Investigational Drug-coated Balloons
Exhibit 9 Impact of Emergence of New Generation DCBs
Exhibit 10 Impact of Global Increase in Target Patient Pool
Exhibit 11 Impact of Increasing Demand for DCBs due to Promising Outcomes
Exhibit 12 Comparison of Vascular Restenosis in DCBs with Other Devices
Exhibit 13 Comparison of Freedom from Target Lesion Revascularization in DCBs with Other Devices
Exhibit 14 Repeat Procedure Rates for Various PAD Treatment Devices
Exhibit 15 Impact of Increased Focus on Generating Abundant Clinical Data
Exhibit 16 Impact of New Product Approvals/Launches
Exhibit 17 Impact of Presence of Alternative Treatment Procedures
Exhibit 18 Common Alternative Treatment Options to DCBs
Exhibit 19 Impact of Stringency in Regulatory Approvals
Exhibit 20 Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies
Exhibit 21 Impact of Lack of Reimbursement Coverage for DCBs
Exhibit 22 COVID-19 Impact on Management of Patients with Acute Coronary Diseases
Exhibit 23 Global Drug-coated Balloons Market 2019–2025 ($ million)
Exhibit 24 Global Drug-coated Balloons Market by Geography
Exhibit 25 Global Drug-coated Balloons Market by Indication
Exhibit 26 Global Drug-coated Balloons Market by Drug Type
Exhibit 27 Global Drug-coated Balloons Market by End-user
Exhibit 28 Five Forces Analysis 2019
Exhibit 29 Incremental Growth by Indication 2019 & 2025
Exhibit 30 The Global Drug-coated Balloons Market by Indication
Exhibit 31 Global Drug-coated Balloons Market by Indication: Incremental Growth
Exhibit 32 Global Drug-coated Balloons Market by Indication: Absolute Growth
Exhibit 33 Global Drug-coated Balloons Market for PAD: Incremental & Absolute Growth
Exhibit 34 Key Benefits Offered by DCBs Compared to Plain Balloon Angioplasty
Exhibit 35 Global Drug-coated Balloons Market for PAD 2019–2025 ($ million)
Exhibit 36 Global Drug-coated Balloons Market for CAD: Incremental & Absolute Growth
Exhibit 37 Global Drug-coated Balloons Market for CAD 2019–2025 ($ million)
Exhibit 38 Global Drug-coated Balloons Market for Others: Incremental & Absolute Growth
Exhibit 39 Global Drug-coated Balloons Market for Other Indications 2019–2025 ($ million)
Exhibit 40 Incremental Growth by Drug Type 2019 & 2025
Exhibit 41 The Global Drug-coated Balloons Market by Drug Type
Exhibit 42 Global Drug-coated Balloons Market by Product: Incremental Growth
Exhibit 43 Global Drug-coated Balloons Market by Product: Absolute Growth
Exhibit 44 Global Paclitaxel-coated Balloons Market: Incremental & Absolute Growth
Exhibit 45 Global Filter Paclitaxel-coated Balloons Market 2019–2025 ($ million)
Exhibit 46 Global Sirolimus-coated Balloons Market: Incremental & Absolute Growth
Exhibit 47 Global Filter Sirolimus-coated Balloons Market 2019–2025 ($ million)
Exhibit 48 Incremental Growth by End-user 2019 & 2025
Exhibit 49 The Global Drug-coated Balloons Market by End-user
Exhibit 50 Global Drug-coated Balloons Market by End-user: Incremental Growth
Exhibit 51 Global Drug-coated balloons market by End-user: Absolute Growth
Exhibit 52 Global Drug-coated Balloons Market by Hospitals: Incremental & Absolute Growth
Exhibit 53 Global Drug-coated Balloons Market by Hospitals 2019–2025 ($ million)
Exhibit 54 Global Drug-coated Balloons Market by Freestanding CATH Labs: Incremental & Absolute Growth
Exhibit 55 Global Drug-coated Balloons Market by Freestanding CATH Labs 2019–2025 ($ million)
Exhibit 56 Global Drug-coated Balloons Market by ASCs: Incremental & Absolute Growth
Exhibit 57 Global Drug-coated Balloons Market by ASCs 2019–2025 ($ million)
Exhibit 58 Incremental Growth by Geography 2019 & 2025
Exhibit 59 The Global Drug-coated Balloons Market by Geography
Exhibit 60 Global Drug-coated Balloons Market by Geography 2019: Key Countries ($ million)
Exhibit 61 Global Drug-coated Balloons Market by Geography: Incremental Growth
Exhibit 62 Global Drug-coated Balloons Market by Geography: Absolute Growth
Exhibit 63 Global Drug-coated Balloons Market in North America 2019
Exhibit 64 North America Drug-coated Balloons Market: Absolute & Incremental Growth
Exhibit 65 Drug-coated Balloons Market in North America 2019–2025 ($ million)
Exhibit 66 Incremental Growth in North America 2019 & 2025
Exhibit 67 Drug-coated Balloons Market in US 2019–2025 ($ million)
Exhibit 68 Drug-coated Balloons Market in Canada 2019–2025 ($ million)
Exhibit 69 Europe Drug-coated Balloons Market: Key Countries 2019
Exhibit 70 Drug-coated Balloons Market in Europe: Incremental & Absolute Growth
Exhibit 71 Number of PCI Procedures Performed with DCBs across Europe in 2016 (per million people)
Exhibit 72 Drug-coated Balloons Market in Europe 2019–2025 ($ million)
Exhibit 73 Incremental Growth in Europe 2019 & 2025
Exhibit 74 Drug-coated Balloons Market in Germany 2019–2025 ($ million)
Exhibit 75 Drug-coated Balloons Market in France 2019–2025 ($ million)
Exhibit 76 Drug-coated Balloons Market in UK 2019–2025 ($ million)
Exhibit 77 Drug-coated Balloons Market in Italy 2019–2025 ($ million)
Exhibit 78 Drug-coated Balloons Market in Spain 2019–2025 ($ million)
Exhibit 79 APAC Drug-coated Balloons Market in 2019
Exhibit 80 APAC Drug-coated Balloons Market: Incremental & Absolute Growth
Exhibit 81 Drug-coated Balloons Market in APAC 2019–2025 ($ million)
Exhibit 82 Population Demographics in APAC
Exhibit 83 Health Access & Quality Index Score for Key APAC Countries 2016
Exhibit 84 Incremental Growth in APAC 2019 & 2025
Exhibit 85 Drug-coated Balloons Market in Japan 2019–2025 ($ million)
Exhibit 86 Drug-coated Balloons Market in China 2019–2025 ($ million)
Exhibit 87 Drug-coated Balloons Market in Australia 2019–2025 ($ million)
Exhibit 88 Drug-coated Balloons Market in South Korea 2019–2025 ($ million)
Exhibit 89 Drug-coated Balloons Market in India 2019–2025 ($ million)
Exhibit 90 Latin America Drug-coated Balloons Market 2019
Exhibit 91 Drug-coated Balloons Market in Latin America: Incremental & Absolute Growth
Exhibit 92 Drug-coated Balloons Market in Latin America 2019–2025 ($ million)
Exhibit 93 Incremental Growth in Latin America 2019 & 2025
Exhibit 94 Drug-coated Balloons Market in Brazil 2019–2025 ($ million)
Exhibit 95 Drug-coated Balloons Market in Mexico 2019–2025 ($ million)
Exhibit 96 Drug-coated Balloons Market in Argentina 2019–2025 ($ million)
Exhibit 97 Middle East & Africa Drug-coated Balloons Market in 2019
Exhibit 98 Middle East & Africa Drug-coated Balloons Market: Incremental & Absolute Growth
Exhibit 99 Drug-coated Balloons Market in Middle East & Africa 2019–2025 ($ million)
Exhibit 100 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 101 Drug-coated Balloons Market in Turkey 2019–2025 ($ million)
Exhibit 102 Drug-coated Balloons Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 103 Drug-coated Balloons Market in Israel 2019–2025 ($ million)
Exhibit 104 Drug-coated Balloons Market in South Africa 2019–2025 ($ million)
Exhibit 105 Market Share (2019)
Exhibit 106 Medtronic: R&D Expenditure 2017?2019 ($ million)
Exhibit 107 Medtronic: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 108 Medtronic: Revenue by Geography 2019 (%)
Exhibit 109 BD: R&D Expenditure 2017?2019 ($ million)
Exhibit 110 BD: Revenue by Business Segments 2018 & 2019 ($ million)
Exhibit 111 BD: Revenue by Geography 2019 (%)
Exhibit 112 Koninklijke Philips: R&D Expenditure 2017?2019 ($ million)
Exhibit 113 Koninklijke Philips: Revenue by Segments 2018 & 2019 ($ million)
Exhibit 114 Koninklijke Philips: Revenue by Geography 2019 (%)
Exhibit 115 Boston Scientific: R&D Expenditure 2017?2019 ($ million)
Exhibit 116 Boston Scientific: Revenue by Business Segments 2018 & 2019 ($ million)
Exhibit 117 Boston Scientific: Revenue by Geography 2019 (%)
Exhibit 118 B. Braun Melsungen: R&D Spend 2017?2019 ($ million)
Exhibit 119 B. Braun Melsungen: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 120 Braun Melsungen: Revenue by Geography 2019 (%)
Exhibit 1 Segmentation of Global Drug-coated Balloons Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Key Application Areas of DCBs
Exhibit 4 Market Dynamics of DCBs
Exhibit 5 Global Drug-coated Balloons Market by Geography 2019 (%)
Exhibit 6 Global Drug-coated Balloons Market by Indication 2019 (%)
Exhibit 7 Impact of Increased Application of DCBs to Treat Medical Disorders
Exhibit 8 Impact of Promising Investigational Drug-coated Balloons
Exhibit 9 Impact of Emergence of New Generation DCBs
Exhibit 10 Impact of Global Increase in Target Patient Pool
Exhibit 11 Impact of Increasing Demand for DCBs due to Promising Outcomes
Exhibit 12 Comparison of Vascular Restenosis in DCBs with Other Devices
Exhibit 13 Comparison of Freedom from Target Lesion Revascularization in DCBs with Other Devices
Exhibit 14 Repeat Procedure Rates for Various PAD Treatment Devices
Exhibit 15 Impact of Increased Focus on Generating Abundant Clinical Data
Exhibit 16 Impact of New Product Approvals/Launches
Exhibit 17 Impact of Presence of Alternative Treatment Procedures
Exhibit 18 Common Alternative Treatment Options to DCBs
Exhibit 19 Impact of Stringency in Regulatory Approvals
Exhibit 20 Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies
Exhibit 21 Impact of Lack of Reimbursement Coverage for DCBs
Exhibit 22 COVID-19 Impact on Management of Patients with Acute Coronary Diseases
Exhibit 23 Global Drug-coated Balloons Market 2019–2025 ($ million)
Exhibit 24 Global Drug-coated Balloons Market by Geography
Exhibit 25 Global Drug-coated Balloons Market by Indication
Exhibit 26 Global Drug-coated Balloons Market by Drug Type
Exhibit 27 Global Drug-coated Balloons Market by End-user
Exhibit 28 Five Forces Analysis 2019
Exhibit 29 Incremental Growth by Indication 2019 & 2025
Exhibit 30 The Global Drug-coated Balloons Market by Indication
Exhibit 31 Global Drug-coated Balloons Market by Indication: Incremental Growth
Exhibit 32 Global Drug-coated Balloons Market by Indication: Absolute Growth
Exhibit 33 Global Drug-coated Balloons Market for PAD: Incremental & Absolute Growth
Exhibit 34 Key Benefits Offered by DCBs Compared to Plain Balloon Angioplasty
Exhibit 35 Global Drug-coated Balloons Market for PAD 2019–2025 ($ million)
Exhibit 36 Global Drug-coated Balloons Market for CAD: Incremental & Absolute Growth
Exhibit 37 Global Drug-coated Balloons Market for CAD 2019–2025 ($ million)
Exhibit 38 Global Drug-coated Balloons Market for Others: Incremental & Absolute Growth
Exhibit 39 Global Drug-coated Balloons Market for Other Indications 2019–2025 ($ million)
Exhibit 40 Incremental Growth by Drug Type 2019 & 2025
Exhibit 41 The Global Drug-coated Balloons Market by Drug Type
Exhibit 42 Global Drug-coated Balloons Market by Product: Incremental Growth
Exhibit 43 Global Drug-coated Balloons Market by Product: Absolute Growth
Exhibit 44 Global Paclitaxel-coated Balloons Market: Incremental & Absolute Growth
Exhibit 45 Global Filter Paclitaxel-coated Balloons Market 2019–2025 ($ million)
Exhibit 46 Global Sirolimus-coated Balloons Market: Incremental & Absolute Growth
Exhibit 47 Global Filter Sirolimus-coated Balloons Market 2019–2025 ($ million)
Exhibit 48 Incremental Growth by End-user 2019 & 2025
Exhibit 49 The Global Drug-coated Balloons Market by End-user
Exhibit 50 Global Drug-coated Balloons Market by End-user: Incremental Growth
Exhibit 51 Global Drug-coated balloons market by End-user: Absolute Growth
Exhibit 52 Global Drug-coated Balloons Market by Hospitals: Incremental & Absolute Growth
Exhibit 53 Global Drug-coated Balloons Market by Hospitals 2019–2025 ($ million)
Exhibit 54 Global Drug-coated Balloons Market by Freestanding CATH Labs: Incremental & Absolute Growth
Exhibit 55 Global Drug-coated Balloons Market by Freestanding CATH Labs 2019–2025 ($ million)
Exhibit 56 Global Drug-coated Balloons Market by ASCs: Incremental & Absolute Growth
Exhibit 57 Global Drug-coated Balloons Market by ASCs 2019–2025 ($ million)
Exhibit 58 Incremental Growth by Geography 2019 & 2025
Exhibit 59 The Global Drug-coated Balloons Market by Geography
Exhibit 60 Global Drug-coated Balloons Market by Geography 2019: Key Countries ($ million)
Exhibit 61 Global Drug-coated Balloons Market by Geography: Incremental Growth
Exhibit 62 Global Drug-coated Balloons Market by Geography: Absolute Growth
Exhibit 63 Global Drug-coated Balloons Market in North America 2019
Exhibit 64 North America Drug-coated Balloons Market: Absolute & Incremental Growth
Exhibit 65 Drug-coated Balloons Market in North America 2019–2025 ($ million)
Exhibit 66 Incremental Growth in North America 2019 & 2025
Exhibit 67 Drug-coated Balloons Market in US 2019–2025 ($ million)
Exhibit 68 Drug-coated Balloons Market in Canada 2019–2025 ($ million)
Exhibit 69 Europe Drug-coated Balloons Market: Key Countries 2019
Exhibit 70 Drug-coated Balloons Market in Europe: Incremental & Absolute Growth
Exhibit 71 Number of PCI Procedures Performed with DCBs across Europe in 2016 (per million people)
Exhibit 72 Drug-coated Balloons Market in Europe 2019–2025 ($ million)
Exhibit 73 Incremental Growth in Europe 2019 & 2025
Exhibit 74 Drug-coated Balloons Market in Germany 2019–2025 ($ million)
Exhibit 75 Drug-coated Balloons Market in France 2019–2025 ($ million)
Exhibit 76 Drug-coated Balloons Market in UK 2019–2025 ($ million)
Exhibit 77 Drug-coated Balloons Market in Italy 2019–2025 ($ million)
Exhibit 78 Drug-coated Balloons Market in Spain 2019–2025 ($ million)
Exhibit 79 APAC Drug-coated Balloons Market in 2019
Exhibit 80 APAC Drug-coated Balloons Market: Incremental & Absolute Growth
Exhibit 81 Drug-coated Balloons Market in APAC 2019–2025 ($ million)
Exhibit 82 Population Demographics in APAC
Exhibit 83 Health Access & Quality Index Score for Key APAC Countries 2016
Exhibit 84 Incremental Growth in APAC 2019 & 2025
Exhibit 85 Drug-coated Balloons Market in Japan 2019–2025 ($ million)
Exhibit 86 Drug-coated Balloons Market in China 2019–2025 ($ million)
Exhibit 87 Drug-coated Balloons Market in Australia 2019–2025 ($ million)
Exhibit 88 Drug-coated Balloons Market in South Korea 2019–2025 ($ million)
Exhibit 89 Drug-coated Balloons Market in India 2019–2025 ($ million)
Exhibit 90 Latin America Drug-coated Balloons Market 2019
Exhibit 91 Drug-coated Balloons Market in Latin America: Incremental & Absolute Growth
Exhibit 92 Drug-coated Balloons Market in Latin America 2019–2025 ($ million)
Exhibit 93 Incremental Growth in Latin America 2019 & 2025
Exhibit 94 Drug-coated Balloons Market in Brazil 2019–2025 ($ million)
Exhibit 95 Drug-coated Balloons Market in Mexico 2019–2025 ($ million)
Exhibit 96 Drug-coated Balloons Market in Argentina 2019–2025 ($ million)
Exhibit 97 Middle East & Africa Drug-coated Balloons Market in 2019
Exhibit 98 Middle East & Africa Drug-coated Balloons Market: Incremental & Absolute Growth
Exhibit 99 Drug-coated Balloons Market in Middle East & Africa 2019–2025 ($ million)
Exhibit 100 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 101 Drug-coated Balloons Market in Turkey 2019–2025 ($ million)
Exhibit 102 Drug-coated Balloons Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 103 Drug-coated Balloons Market in Israel 2019–2025 ($ million)
Exhibit 104 Drug-coated Balloons Market in South Africa 2019–2025 ($ million)
Exhibit 105 Market Share (2019)
Exhibit 106 Medtronic: R&D Expenditure 2017?2019 ($ million)
Exhibit 107 Medtronic: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 108 Medtronic: Revenue by Geography 2019 (%)
Exhibit 109 BD: R&D Expenditure 2017?2019 ($ million)
Exhibit 110 BD: Revenue by Business Segments 2018 & 2019 ($ million)
Exhibit 111 BD: Revenue by Geography 2019 (%)
Exhibit 112 Koninklijke Philips: R&D Expenditure 2017?2019 ($ million)
Exhibit 113 Koninklijke Philips: Revenue by Segments 2018 & 2019 ($ million)
Exhibit 114 Koninklijke Philips: Revenue by Geography 2019 (%)
Exhibit 115 Boston Scientific: R&D Expenditure 2017?2019 ($ million)
Exhibit 116 Boston Scientific: Revenue by Business Segments 2018 & 2019 ($ million)
Exhibit 117 Boston Scientific: Revenue by Geography 2019 (%)
Exhibit 118 B. Braun Melsungen: R&D Spend 2017?2019 ($ million)
Exhibit 119 B. Braun Melsungen: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 120 Braun Melsungen: Revenue by Geography 2019 (%)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2019
Table 3 Extended Indications for DCBs
Table 4 Major Pipeline DCBs
Table 5 Major Latest-generation DCBs Available in Market
Table 6 Global Drug-coated Balloons Market: Major Clinical Trials Conducted on DCBs by Various Vendors
Table 7 Product Approvals/Launches in Global Drug-coated Balloons Market 2016?2020
Table 8 Significant Players Offering DCBs for PAD Indications
Table 9 Significant Players Offering DCBs for CAD Intervention
Table 10 Significant Players Offering DCBs for Others
Table 11 Key Paclitaxel-coated Balloons Offered by Significant Players
Table 12 Key Sirolimus-coated Balloons Offered by Significant Players
Table 13 Provincial Reimbursement Policy in China
Table 14 Competitive Structure of the Global Drug-coated Balloons Market
Table 15 Global Drug-coated Balloons Market: Vendors Ranking 2019
Table 16 Medtronic: Major Product Offerings
Table 17 BD: Major Product Offerings
Table 18 Koninklijke Philips: Major Product Offerings
Table 19 Boston Scientific: Major Product Offerings
Table 20 B. Braun Melsungen: Major Product Offerings
Table 21 Aachen Resonance: Major Product Offerings
Table 22 Acotec Scientific: Major Product Offerings
Table 23 AR Baltic Medical: Major Product Offerings
Table 24 Biosensors International Group: Major Product Offerings
Table 25 BIOTRONIK: Major Product Offerings
Table 26 Cardionovum: Major Product Offerings
Table 27 Concept Medical: Major Product Offerings
Table 28 eucatech: Major Product Offerings
Table 29 ENDOCOR: Major Product Offerings
Table 30 HEXACATH: Major Product Offerings
Table 31 iVascular: Major Product Offerings
Table 32 M.A. Med Alliance: Major Product Offerings
Table 33 Meril Life Sciences: Major Product Offerings
Table 34 Nano Therapeutics: Major Product Offerings
Table 35 QT Vascular: Major Product Offerings
Table 36 RD Global-Invamed: Major Product Offerings
Table 37 STENTYS: Major Product Offerings
Table 38 Surmodics: Major Product Offerings
Table 39 Terumo: Major Product Offerings
Table 40 Urotronic: Major Product Offerings
Table 41 Wellinq: Major Product Offerings
Table 42 MICELL TECHNOLOGIES: Investigational Product
Table 43 Orchestra BioMed: Major Investigational Products
Table 44 Global Drug-coated Balloons Market by Indication 2019?2025 ($ million)
Table 45 Global Drug-coated Balloons Market by Indication 2019?2025 (%)
Table 46 Global Drug-coated Balloons Market by Drug Type 2019?2025 ($ million)
Table 47 Global Drug-coated Balloons Market by Drug Type 2019?2025 (%)
Table 48 Global Drug-coated Balloons Market by End-user 2019?2025 ($ million)
Table 49 Global Drug-coated Balloons Market by End-user 2019?2025 (%)
Table 50 Global Drug-coated Balloons Market by Geography 2019?2025 ($ million)
Table 51 Global Drug-coated Balloons Market by Geography 2019?2025 (%)
Table 1 Key Caveats
Table 2 Currency Conversion 2013?2019
Table 3 Extended Indications for DCBs
Table 4 Major Pipeline DCBs
Table 5 Major Latest-generation DCBs Available in Market
Table 6 Global Drug-coated Balloons Market: Major Clinical Trials Conducted on DCBs by Various Vendors
Table 7 Product Approvals/Launches in Global Drug-coated Balloons Market 2016?2020
Table 8 Significant Players Offering DCBs for PAD Indications
Table 9 Significant Players Offering DCBs for CAD Intervention
Table 10 Significant Players Offering DCBs for Others
Table 11 Key Paclitaxel-coated Balloons Offered by Significant Players
Table 12 Key Sirolimus-coated Balloons Offered by Significant Players
Table 13 Provincial Reimbursement Policy in China
Table 14 Competitive Structure of the Global Drug-coated Balloons Market
Table 15 Global Drug-coated Balloons Market: Vendors Ranking 2019
Table 16 Medtronic: Major Product Offerings
Table 17 BD: Major Product Offerings
Table 18 Koninklijke Philips: Major Product Offerings
Table 19 Boston Scientific: Major Product Offerings
Table 20 B. Braun Melsungen: Major Product Offerings
Table 21 Aachen Resonance: Major Product Offerings
Table 22 Acotec Scientific: Major Product Offerings
Table 23 AR Baltic Medical: Major Product Offerings
Table 24 Biosensors International Group: Major Product Offerings
Table 25 BIOTRONIK: Major Product Offerings
Table 26 Cardionovum: Major Product Offerings
Table 27 Concept Medical: Major Product Offerings
Table 28 eucatech: Major Product Offerings
Table 29 ENDOCOR: Major Product Offerings
Table 30 HEXACATH: Major Product Offerings
Table 31 iVascular: Major Product Offerings
Table 32 M.A. Med Alliance: Major Product Offerings
Table 33 Meril Life Sciences: Major Product Offerings
Table 34 Nano Therapeutics: Major Product Offerings
Table 35 QT Vascular: Major Product Offerings
Table 36 RD Global-Invamed: Major Product Offerings
Table 37 STENTYS: Major Product Offerings
Table 38 Surmodics: Major Product Offerings
Table 39 Terumo: Major Product Offerings
Table 40 Urotronic: Major Product Offerings
Table 41 Wellinq: Major Product Offerings
Table 42 MICELL TECHNOLOGIES: Investigational Product
Table 43 Orchestra BioMed: Major Investigational Products
Table 44 Global Drug-coated Balloons Market by Indication 2019?2025 ($ million)
Table 45 Global Drug-coated Balloons Market by Indication 2019?2025 (%)
Table 46 Global Drug-coated Balloons Market by Drug Type 2019?2025 ($ million)
Table 47 Global Drug-coated Balloons Market by Drug Type 2019?2025 (%)
Table 48 Global Drug-coated Balloons Market by End-user 2019?2025 ($ million)
Table 49 Global Drug-coated Balloons Market by End-user 2019?2025 (%)
Table 50 Global Drug-coated Balloons Market by Geography 2019?2025 ($ million)
Table 51 Global Drug-coated Balloons Market by Geography 2019?2025 (%)
